Upgrade to SI Premium - Free Trial

Johnson & Johnson (JNJ) Janssen Gains FDA Approval for Plaque Psoriasis Treatment TREMFYA

July 13, 2017 4:12 PM
Johnson & Johnson's (NYSE: JNJ) Janssen Biotech, Inc.(Janssen) announced today that the U.S. Food and Drug Administration (FDA) has approved ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles